Shopping Cart
- Remove All
- Your shopping cart is currently empty
BI 7446 is a potent and selective cyclic dinucleotide (CDN)-based stimulator of interferon genes (STING) agonist capable of activating all five STING variants in cells, thus inducing tumor-specific immune-mediated tumor rejection. This compound is utilized in immuno-oncology research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | BI 7446 is a potent and selective cyclic dinucleotide (CDN)-based stimulator of interferon genes (STING) agonist capable of activating all five STING variants in cells, thus inducing tumor-specific immune-mediated tumor rejection. This compound is utilized in immuno-oncology research [1]. |
In vitro | BI 7446 (CDN13) at concentrations of 3 μM and 10 μM over 6 hours enhances the phosphorylation of IRF3 and TBK1 in THP1 STING wild-type cells [1]. |
In vivo | BI 7446 (CDN13) administered intravenously at doses of 4, 12, and 36 μg with detection time points up to 25 hours exhibited high plasma clearance and a short elimination half-life in the 4T1 tumor mouse model [1]. Similarly, subcutaneous injections of BI 7446 at 0.25, 1, and 4 μg once weekly resulted in tumor regression in the EMT breast cancer mouse model and generated long-term immune memory against autologous tumor rechallenge [1]. |
Molecular Weight | 693.52 |
Formula | C20H22FN9O10P2S2 |
Cas No. | 2767011-00-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.